PREETI CHOPRA
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- CAMARILLO, CA
- NPI
- 1699951202
- Received
- $111,034 in 1,043 records, 2019 to 2025
- As principal investigator
- $342,093 of research payments to others in 45 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 192 | $22,850 |
| 2024 | General payment | 159 | $19,337 |
| 2023 | General payment | 183 | $42,233 |
| 2022 | General payment | 192 | $6,274 |
| 2021 | General payment | 140 | $3,913 |
| 2020 | General payment | 91 | $3,468 |
| 2019 | General payment | 86 | $12,957 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 35 | $56,194 |
| Food and Beverage | 967 | $28,111 |
| Consulting Fee | 8 | $12,743 |
| Travel and Lodging | 29 | $9,836 |
| Honoraria | 2 | $4,063 |
| Education | 2 | $85 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-12-18 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-12-17 | Ionis Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-12-16 | AstraZeneca Pharmaceuticals LP | $590 | Consulting Fee | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-12-16 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-12 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-12-10 | GENZYME CORPORATION | $76 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-12-10 | GlaxoSmithKline, LLC. | $50 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-05 | GENZYME CORPORATION | $31 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-12-05 | GlaxoSmithKline, LLC. | $30 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-02 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-12-01 | Paratek Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | XHANCE Drug, CORTICOSTEROID | 2025 | |
| 2025-11-25 | CSL Behring | $428 | Travel and Lodging | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-25 | CSL Behring | $383 | Travel and Lodging | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-25 | CSL Behring | $42 | Food and Beverage | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-25 | CSL Behring | $42 | Travel and Lodging | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-25 | CSL Behring | $42 | Travel and Lodging | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-25 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-11-21 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-11-21 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-11-21 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-11-20 | CSL Behring | $7,068 | Consulting Fee | Cash or cash equivalent | Hizentra Biological, Immunology | 2025 | |
| 2025-11-19 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-11-18 | Amgen Inc. | $10 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-11-17 | GlaxoSmithKline, LLC. | $27 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-17 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-11-14 | Incyte Corporation | $27 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-11-13 | Jubilant HollisterStier LLC | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-13 | GENZYME CORPORATION | $11 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-11-12 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-12 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-08 | GENZYME CORPORATION | $58 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-11-08 | AstraZeneca Pharmaceuticals LP | $43 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-07 | AstraZeneca Pharmaceuticals LP | $140 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-06 | AstraZeneca Pharmaceuticals LP | $81 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-05 | CSL Behring | $105 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-11-05 | CSL Behring | $58 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-10-31 | Greer Laboratories, Inc. | $95 | Food and Beverage | In-kind items and services | ORALAIR Biological, Allergy Treatment | 2025 | |
| 2025-10-31 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-30 | Novartis Pharmaceuticals Corporation | $96 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-30 | Regeneron Healthcare Solutions, Inc. | $7 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-10-29 | Amgen Inc. | $150 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-10-28 | Amgen Inc. | $150 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-10-28 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-28 | Novartis Pharmaceuticals Corporation | $2 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-27 | Ionis Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-10-22 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-22 | GlaxoSmithKline, LLC. | $1 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-21 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-20 | AstraZeneca Pharmaceuticals LP | $3,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-17 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-10-15 | LEO Pharma Inc. | $29 | Food and Beverage | In-kind items and services | ADBRY Biological, DERMATOLOGY | 2025 | |
| 2025-10-14 | AstraZeneca Pharmaceuticals LP | $29 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-10 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-10-09 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-08 | Novartis Pharmaceuticals Corporation | $106 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-08 | ARS Pharmaceuticals Operations, Inc. | $24 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-10-07 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-10-06 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-06 | Novartis Pharmaceuticals Corporation | $2 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-01 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-26 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-09-25 | AstraZeneca Pharmaceuticals LP | $1,456 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-25 | AstraZeneca Pharmaceuticals LP | $145 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-19 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-09-18 | CSL Behring | $30 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-17 | CSL Behring | $33 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-17 | GlaxoSmithKline, LLC. | $9 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-17 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-16 | Regeneron Healthcare Solutions, Inc. | $9 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-09-16 | GlaxoSmithKline, LLC. | $3 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-12 | Lilly USA, LLC | $26 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-09-12 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-09-05 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-03 | Galderma Laboratories, L.P. | $20 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-09-03 | Regeneron Healthcare Solutions, Inc. | $7 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-09-02 | Novartis Pharmaceuticals Corporation | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-02 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-27 | Genentech USA, Inc. | $31 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-08-22 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-08-20 | Greer Laboratories, Inc. | $24 | Food and Beverage | In-kind items and services | ORALAIR Biological, Allergy Treatment | 2025 | |
| 2025-08-18 | GENZYME CORPORATION | $113 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-08-18 | GENZYME CORPORATION | $23 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-08-15 | Regeneron Healthcare Solutions, Inc. | $14 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-08-09 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-08-08 | AstraZeneca Pharmaceuticals LP | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-05 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-01 | Incyte Corporation | $28 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-08-01 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-01 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-30 | Optinose US, Inc. | $17 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-07-29 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-07-29 | Octapharma USA, Inc. | $35 | Food and Beverage | In-kind items and services | CUTAQUIG Biological, IMMUNOLOGY | 2025 | |
| 2025-07-29 | GENZYME CORPORATION | $12 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-28 | Lilly USA, LLC | $31 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-07-25 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-23 | AstraZeneca Pharmaceuticals LP | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-18 | Grifols USA, LLC | $18 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2025 | |
| 2025-07-18 | Regeneron Healthcare Solutions, Inc. | $10 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-07-16 | GENZYME CORPORATION | $73 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-16 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-07-16 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-07-16 | Genentech USA, Inc. | $4 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-07-15 | Incyte Corporation | $28 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-07-11 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-07 | Blueprint Medicines Corporation | $26 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2025 | |
| 2025-07-03 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-02 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-07-02 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-01 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-06-25 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-06-21 | Regeneron Healthcare Solutions, Inc. | $32 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-06-19 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-18 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $5 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-06-16 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-06-11 | Novartis Pharmaceuticals Corporation | $53 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-11 | Greer Laboratories, Inc. | $28 | Food and Beverage | In-kind items and services | ORALAIR Biological, Allergy Treatment | 2025 | |
| 2025-06-09 | GlaxoSmithKline, LLC. | $29 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-06 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-04 | Genentech USA, Inc. | $19 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-06-04 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-06-03 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug, IMMUNOLOGY | 2025 | |
| 2025-06-03 | GENZYME CORPORATION | $8 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-05-27 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-21 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-05-20 | GlaxoSmithKline, LLC. | $25 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-20 | Regeneron Healthcare Solutions, Inc. | $10 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-05-17 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-13 | AstraZeneca Pharmaceuticals LP | $125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-13 | AstraZeneca Pharmaceuticals LP | $100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-13 | Novartis Pharmaceuticals Corporation | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-13 | Incyte Corporation | $12 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-05-12 | Blueprint Medicines Corporation | $30 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2025 | |
| 2025-05-09 | ARS Pharmaceuticals Operations, Inc. | $29 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-05-05 | GlaxoSmithKline, LLC. | $34 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-05 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-05 | AstraZeneca Pharmaceuticals LP | $18 | Travel and Lodging | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-02 | Cycle Pharmaceuticals Inc | $24 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-04-30 | Genentech USA, Inc. | $27 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-04-16 | ARS Pharmaceuticals Operations, Inc. | $26 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-04-15 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-04-11 | GENZYME CORPORATION | $35 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-04-11 | GlaxoSmithKline, LLC. | $8 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-04-10 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-04-09 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-04-01 | AstraZeneca Pharmaceuticals LP | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-04-01 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-03-30 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-03-29 | ARS Pharmaceuticals Operations, Inc. | $24 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-03-28 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-03-28 | AstraZeneca Pharmaceuticals LP | $19 | Travel and Lodging (2 payments) | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-03-28 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-03-21 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-03-21 | GlaxoSmithKline, LLC. | $7 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-03-21 | GlaxoSmithKline, LLC. | $0 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-03-18 | Octapharma USA, Inc. | $29 | Food and Beverage | In-kind items and services | CUTAQUIG Biological, IMMUNOLOGY | 2025 | |
| 2025-03-11 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-03-07 | Incyte Corporation | $24 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-03-07 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-03-07 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-03-04 | BioCryst US Sales Co., LLC | $20 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2025 | |
| 2025-03-03 | AstraZeneca Pharmaceuticals LP | $29 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-03-02 | ALK-Abello, Inc | $152 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-02 | AstraZeneca Pharmaceuticals LP | $74 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-03-02 | AstraZeneca Pharmaceuticals LP | $64 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-01 | AstraZeneca Pharmaceuticals LP | $90 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-03-01 | GENZYME CORPORATION | $41 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-02-28 | AstraZeneca Pharmaceuticals LP | $134 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-28 | Amgen Inc. | $129 | Food and Beverage | In-kind items and services | ACTIMMUNE Biological, Bone/Inflammation/Rare Disease | 2025 | |
| 2025-02-28 | Amgen Inc. | $49 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-02-27 | AstraZeneca Pharmaceuticals LP | $46 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-02-25 | Genentech USA, Inc. | $18 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-02-25 | Optinose US, Inc. | $18 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-02-21 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-02-21 | GENZYME CORPORATION | $10 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-02-18 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-02-10 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | XOLAIR Drug, Pulmonary/Respiratory Diseases | 2025 | |
| 2025-02-04 | GlaxoSmithKline, LLC. | $33 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-02-03 | AstraZeneca Pharmaceuticals LP | $27 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-02-01 | Incyte Corporation | $28 | Food and Beverage | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2025 | |
| 2025-01-28 | Genentech USA, Inc. | $17 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-01-27 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-01-24 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-01-17 | Optinose US, Inc. | $20 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-01-17 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-01-16 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-01-13 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-01-07 | ARS Pharmaceuticals Operations, Inc. | $18 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-01-06 | AstraZeneca Pharmaceuticals LP | $133 | Food and Beverage (17 payments) | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2024-12-20 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | XOLAIR Drug, Pulmonary/Respiratory Diseases | 2024 | |
| 2024-12-17 | GENZYME CORPORATION | $12 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-12-17 | GlaxoSmithKline, LLC. | $4 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-12-13 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2024 | |
| 2024-12-11 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | EUCRISA Drug, DERMATOLOGY | 2024 | |
| 2024-12-10 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-12-07 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-12-07 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2024 |
The latest 200 records of 1,043.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-10 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $215 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $5,005 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $1,127 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $2,000 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-09-19 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $1,200 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $6,437 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-08-01 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $1,768 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-08-01 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $107 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-06-06 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $2,425 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-06-06 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $3,000 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-05-16 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $15,000 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-04-23 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-04-09 | AstraZeneca Pharmaceuticals LP | AVICENNA DM CLINICAL RESEARCH | $6,000 | A Randomized Double-Blind Parallel Group Multicenter 12 Week Study to Assess the Efficacy and Safety of Budesonide and F | 2025 |
| 2025-04-04 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $777 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-03-28 | Teva Pharmaceuticals USA, Inc. | FOMAT MEDICAL RESEARCH INC | $215 | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate | 2025 |
| 2025-03-19 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH | $8,950 | A Randomized Double-Blind Parallel Group Multicenter 12 Week Study to Assess the Efficacy and Safety of Budesonide and F | 2025 |
| 2025-03-07 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $2,348 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-02-24 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $57,905 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2025 |
| 2025-02-21 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH | $9,400 | A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Effi | 2025 |
| 2025-02-07 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $1,191 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-01-13 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $753 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-01-03 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH | $2,500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2024-12-11 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $1,491 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-11-22 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-11-06 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $753 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-09-25 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $979 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-09-06 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $2,931 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-08-14 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $885 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-08-02 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $2,000 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-07-29 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $16,895 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2024 |
| 2024-07-24 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-07-08 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $1,023 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-07-03 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-06-14 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $885 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-05-08 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH INCORPORATED | $13,899 | A Randomized Double-Blind Parallel Group Multicenter 12 Week Study to Assess the Efficacy and Safety of Budesonide and F | 2024 |
| 2024-05-08 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $1,265 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-04-15 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $10,702 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-03-25 | GlaxoSmithKline, LLC. | FOMAT MEDICAL RESEARCH INCORPORATED | $19,116 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-01-31 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH INCORPORATED | $28,254 | A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Effi | 2024 |
| 2023-06-16 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH INCORPORATED | $20,000 | A Randomized Double-Blind Parallel Group Multicenter 12 Week Study to Assess the Efficacy and Safety of Budesonide and F | 2023 |
| 2023-06-14 | AstraZeneca Pharmaceuticals LP | FOMAT MEDICAL RESEARCH INCORPORATED | $23,635 | A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Effi | 2023 |
| 2023-01-25 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $22,977 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2023 |
| 2022-02-14 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $14,032 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2022 |
| 2021-01-04 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $13,729 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2021 |
| 2020-03-19 | AstraZeneca Pharmaceuticals LP | ALLERGY, ASTHMA, AND IMMUNOLOGY MEDICAL GROUP | $16,305 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Camarillo, CA, county Ventura County, CA, state California; placed by its city name.
| Measure | Place (city or town) Camarillo, CA | County Ventura County, CA | State California |
|---|---|---|---|
| Population B01003 | 70,186 | 837,469 | 39,287,377 |
| Population, 2020 census P1 | 70,741 | 843,843 | 39,538,223 |
| Median age B01002 | 41.2 | 39.6 | 37.9 |
| Under 18 B01001 | 20.7% | 21.8% | 22.0% |
| 65 and over B01001 | 23.0% | 17.4% | 15.7% |
| Households B11001 | 26,250 | 280,360 | 13,548,091 |
| Foreign born B05002 | 16.2% | 22.2% | 27.0% |
| Median household income B19013 | $113,428 | $109,797 | $99,122 |
| Median family income B19113 | $136,019 | $125,818 | $113,346 |
| Per capita income B19301 | $57,383 | $49,748 | $49,513 |
| Poverty rate B17001 | 8.5% | 9.3% | 12.0% |
| Unemployment rate B23025 | 5.5% | 5.7% | 6.6% |
| Civilian labor force B23025 | 34,140 | 431,630 | 20,068,466 |
| Mean commute (minutes) B08013 | 23.0 | 25.6 | 28.7 |
| Bachelor's degree or higher B15003 | 43.6% | 36.1% | 37.1% |
| Housing units B25001 | 27,658 | 295,878 | 14,644,735 |
| Owner-occupied B25003 | 64.6% | 64.6% | 55.9% |
| Renters B25003 | 35.4% | 35.4% | 44.1% |
| Median home value B25077 | $827,300 | $822,700 | $734,700 |
| Median gross rent B25064 | $2,734 | $2,317 | $2,036 |
| White, not Hispanic B03002 | 49.3% | 41.9% | 33.8% |
| Black B03002 | 3.0% | 1.7% | 5.2% |
| Hispanic or Latino B03002 | 30.3% | 44.3% | 40.2% |
| Asian B03002 | 11.1% | 7.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.3% | 0.1% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Camarillo, CA.
Comments